| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 249,134 | 222,685 | 209,179 | 300,339 | | Cost of Revenue | 56,272 | 58,206 | 64,229 | 80,340 | | | Gross Profit | 192,862 | 164,479 | 144,950 | 219,999 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 32,997 | 35,157 | 38,099 | 147,161 | | Non Recurring | 8,409 | 256 | 791,137 | 1,585,775 | | Others | 59,240 | 56,885 | 89,666 | 141,215 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 74,603 | 72,181 | (773,952) | (1,654,152) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (21,350) | (5,535) | (2,355) | 2,735 | | Earnings Before Interest And Taxes | 70,866 | 66,646 | (776,307) | (1,651,417) | | Interest Expense | 5,328 | 5,832 | 2,754 | 214 | | Income Before Tax | 65,538 | 60,814 | (779,061) | (1,651,631) | | Income Tax Expense | 26,833 | 22,007 | (284,961) | (602,932) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 38,705 | 38,807 | (494,100) | (1,048,699) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 38,705 | 38,807 | (494,100) | (1,048,699) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $38,705 | $38,807 | ($494,100) | ($1,048,699) |
|
0.01% Nasdaq 
Income Statement
